Using a smartwatch to track tremor control from deep brain stimulation
Tests an Apple Watch in essential tremor treated with brain stimulation.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- A Study of Wearable Device in Essential Tremor Patients
- Status
- Enrolling by invitation
- People taking part
- 50 people, planned
- Started
- 7 Jul 2023
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- Apple Watch
- BrainRISE app
- Record updated
- 2 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with essential tremor who already get regular deep brain stimulation (DBS) therapy at Mayo Clinic. They wear an Apple Watch and do tremor tasks in an app 4 times a day for two weeks.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Clearly diagnosed essential tremor.
- Earlier treatment
- Must already have a DBS system implanted and receive regular DBS therapy at Mayo Clinic.
Main reasons for not taking part
- A memory, thinking or mental health condition that makes it hard to help collect data or to manage and charge the watch and tablet
- Open or healing wounds near the places where the devices are worn
- Unable or unwilling to give written consent, by yourself or through a legal guardian or representative
- Not able to use a smart phone well
- Not willing to do daily tasks in the BrainRISE app or to allow video and audio recording
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients with well-classified essential tremor, who are already receiving regular DBS therapy at Mayo Clinic for their movement disorder
- Ability to understand study procedures and to comply with them for the entire length of the study and use study devices as outlined in protocol
- Patient agrees to perform daily tasks in BrainRISE app and consents to the study collecting video and audio recordings during those tasks
- Proficient in the use of a smart phone
Who cannot take part
- Cognitive or psychiatric condition rendering a patient unable to cooperate with data collection, or to manage and recharge smart watch and tablet computer devices
- Presence of open or healing wounds near monitoring sites (infection risk)
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent
Where in United States
- Mayo Clinic MinnesotaRochester, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose of this research is to observe the daily loss of benefit from DBS therapy by performing a standardized set of tasks throughout the day while wearing an Apple Watch to collect movement and other physiological data.
The group in the trial
- Wearable device for tremor assessmentTreatment being tested
Subjects already implanted with a deep brain stimulation (DBS) system for therapy for essential tremor wear an Apple Watch and complete tremor assessment tasks detailed through the BrainRISE app four times a day for two weeks.
Treatment: Apple Watch and BrainRISE app
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Prospective Feasibility Study Evaluating the Use of Wearable Devices to Quantify Tolerance to Deep Brain Stimulation in Essential Tremor Patients
- Plain-language title
- Using a smartwatch to track tremor control from deep brain stimulationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 2 October 2026